|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 |
| (11) | Number of the document | 2485761 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10822810.7 |
| Date of filing the European patent application | 2010-10-08 | |
| (97) | Date of publication of the European application | 2012-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/052113 |
| Date | 2010-10-08 |
| (87) | Number | WO 2011/044542 |
| Date | 2011-04-14 |
| (30) | Number | Date | Country code |
| 256049 P | 2009-10-29 | US | |
| 250378 P | 2009-10-09 | US |
| (72) |
PARDRIDGE, William, M., US
BOADO, Ruben, J., US
|
| (73) |
Armagen, Inc.,
30301 Agoura Road No.110, Agoura Hills, CA 91301,
US
|
| (54) | METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATASE ACTIVITY IN THE CNS |
| METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATASE ACTIVITY IN THE CNS |